# Lilly del Caribe, Inc., Carolina, PR – FDA Inspections

Source: https://www.keypedia.com/companies/lilly-del-caribe-inc/7961ecde-19e4-4ccc-9701-c1979bc57aaa

> Inspection records and compliance data for Lilly del Caribe, Inc. in Carolina, Puerto Rico. 9 FDA inspections on record (1 OAI), 1 Form 483, last inspected May 12, 2026.

---

## Details

- Name: Lilly del Caribe, Inc.
- FEI Number: 3004525072
- Address Line 1: 12.3 Km 65th Infantry Road (Pr05)
- City: Carolina
- State: Puerto Rico
- Zip Code: 00985
- Country Name: United States
- Address: 12.3 Km 65th Infantry Road (Pr05), Carolina, Puerto Rico 00985, United States
- Country: United States

## Related Documents

- FDA Inspection 1321482 - Lilly del Caribe, Inc. - 2026-05-12 — source: FDA, date: May 12, 2026
- [483 - Lilly del Caribe, Inc. - 2023-02-17](https://www.keypedia.com/records/483/lilly-del-caribe-inc/0077c94c-6068-4f48-9c88-b92150dd9273) — source: FDA, date: February 17, 2023
- [FDA Inspection 1198613 - Lilly del Caribe, Inc. - 2023-02-17](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/c2c92c4c-c540-4128-90a5-30550b167b83) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 17, 2023
- FDA Inspection 1069980 - Lilly del Caribe, Inc. - 2018-09-27 — classification: No Action Indicated (NAI), source: FDA, date: September 27, 2018
- FDA Inspection 974723 - Lilly del Caribe, Inc. - 2016-06-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2016
- FDA Inspection 868382 - Lilly del Caribe, Inc. - 2014-02-21 — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2014
- FDA Inspection 776200 - Lilly del Caribe, Inc. - 2012-04-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2012
- [FDA Inspection 721435 - Lilly del Caribe, Inc. - 2011-04-28](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/21f596f1-08d7-493f-aeaf-fe74e0c923c6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2011
- [FDA Inspection 682973 - Lilly del Caribe, Inc. - 2010-09-15](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/45f81be8-2bfe-4200-b122-82cea0abdbfb) — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2010
- [FDA Inspection 600975 - Lilly del Caribe, Inc. - 2009-07-31](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/0fa8b6f9-1bcb-444c-8eed-141674da7034) — classification: Official Action Indicated (OAI), source: FDA, date: July 31, 2009

## Related Companies

- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/2da83be9-1e31-4fdf-af6b-4ad88608bebc)
- [AMPAC Fine Chemicals LLC](https://www.keypedia.com/companies/ampac-fine-chemicals-llc/f74e86b7-21d5-4da6-ae23-b2f2c1c2ea30)
- [F. Hoffmann-La Roche AG](https://www.keypedia.com/companies/f-hoffmann-la-roche-ag/32148dda-fc73-4c59-98ba-f5483a05f328)
- [PolyPeptide Laboratories San Diego LLC](https://www.keypedia.com/companies/polypeptide-laboratories-san-diego-llc/9434fe37-e287-4a78-893a-9ca45515b552)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/9dd52d78-ca3e-4520-bf08-4077a46010a8)
- [Unichem Laboratories Ltd](https://www.keypedia.com/companies/unichem-laboratories-ltd/213f12ee-68ce-424a-a17e-c0c414f8ca53)
- [Interquim S.A.](https://www.keypedia.com/companies/interquim-sa/97e3ab74-e2ba-4b9a-8932-8b7e15c0d511)
- [Lonza Manufacturing LLC](https://www.keypedia.com/companies/lonza-manufacturing-llc/776c279b-12bf-428b-9f69-67f9fbd534d1)
- [Sun Pharmaceutical Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/a3b25a73-6014-41fa-802f-abd1fe33382c)
- [Yuhan Chemical, Inc.](https://www.keypedia.com/companies/yuhan-chemical-inc/ab32ef04-730e-4d05-a241-f163d065a70d)

## Related Officers

- [Angelica M. Hernandez](https://www.keypedia.com/people/angelica-m-hernandez/d66d920c-01b6-4770-a1b5-cac9a1790a0e)
- [investigator](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)